Cell and Gene Therapy CDMO Market Soars to US$ 18.6 billion, Fueling Breakthrough Innovations and Transforming Patient Care



 According to research report “Cell and Gene Therapy CDMO  Market was valued at US$ 4.4 Billion in 2024 and is projected to grow at a CAGR of 28.90%to reach US$ 44.7 Billion by 2034”

 What is the Overview of Cell and Gene Therapy CDMO Market?

Cell and gene therapies (CAGT) are used in treating various diseases like heart disease, cancer, diabetes, neurological disorders, and infectious diseases. CAGT has potential for addressing the root cause of genetic and acquired diseases and provides concepts and techniques that can be used in reproductive potential and remodeling, and gene regulation.

Growing prevalence of cancer disease has become major factor in market growth. Rising demand for CDMOs (Contract Development and Manufacturing Organization) from emerging pharmaceutical and biotech companies has further boot the demand for market growth. Growing trend of outsourcing manufacturing activities and wide benefits of CDMOs is expected to provide lucrative opportunities in Cell and Gene Therapy CDMO market growth.

Who are the Key Vendors in Cell and Gene Therapy CDMO Market?

·         Catalent Inc

·         Lonza Group

·         Recipharm AB

·         Wuxi Advanced Therapies

·         Pfizer CentreOne

·         Charles River Laboratories International Inc

·         Patheon Inc

·         Almac Group

·         FUJIFILM Diosynth Biotechnologies

·         PCI Pharma Services

Request Sample Copy of Cell and Gene Therapy CDMO Market Research Report @

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5065

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)

What is Prophecy’s Analyst View on Cell and Gene Therapy CDMO Market?

Rising number of clinical trials has become a major driver of target market expansion. Growing demand for novel therapies and rising research and development activities has further fueled the market growth. Benefits of CDMOs in cell and gene therapy to make process of drug development in efficient and cost-effective manner is expected to power the demand for Cell and Gene Therapy CDMO market growth over the forecast period.

What are the Possibilities for Growth Cell and Gene Therapy CDMO Market?

·         Increasing Adoption of Cell and Gene Therapies: The field of cell and gene therapies is rapidly advancing, with a growing number of promising treatments in development.

·         Expanding Pipeline of Cell and Gene Therapy Candidates: The pipeline of cell and gene therapy candidates continues to expand across various therapeutic areas, including oncology, genetic disorders, autoimmune diseases, and cardiovascular diseases.

·         Increasing Outsourcing Trends: Many biopharmaceutical companies are outsourcing their cell and gene therapy manufacturing to specialized CDMOs.

·         Advancements in Manufacturing Technologies: Continuous advancements in manufacturing technologies, such as automation, process optimization, and closed-system manufacturing, are enhancing the efficiency and scalability of cell and gene therapy production.

·         Favorable Regulatory Environment: Regulatory authorities are increasingly supporting the development and commercialization of cell and gene therapies.

·         Growing Investment in Cell and Gene Therapy Manufacturing: The cell and gene therapy sector has attracted substantial investment from both established pharmaceutical companies and venture capital firms.

What is COVID-19’s Impact on Cell and Gene Therapy CDMO Market?

·         Increased Demand for Vaccine Manufacturing: The urgent need for COVID-19 vaccines has led to a surge in manufacturing requirements. Many CDMOs with expertise in cell and gene therapy manufacturing have pivoted their resources and capabilities to support vaccine production.

·         Disruption of Clinical Trials: The pandemic has disrupted ongoing clinical trials across various therapeutic areas, including cell and gene therapies. Restrictions on patient recruitment, site closures, and disruptions in supply chains have delayed trial timelines.

·         Increased Focus on Supply Chain Resilience: The pandemic exposed vulnerabilities in global supply chains. The cell and gene therapy field relies on complex supply chains for raw materials, reagents, and critical components. As a result, there has been a heightened focus on building resilient supply chains and reducing dependencies on single sourcing.

·         Delayed Investments and Funding: The economic impact of the pandemic has led to some delays in investments and funding for cell and gene therapy programs. Biotech companies and startups may face challenges in securing necessary funding, which could affect their engagement with CDMOs for manufacturing and development services.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com



Comments

Post a Comment

Popular posts from this blog

Food Allergy Market is estimated to be US$ 7.0 Bn by 2030 with a CAGR of 7.9% during the forecast period

Image
  The Food Allergy Market accounted for US$ 3.3 Bn in 2020 and is estimated to be US$ 7.0 Bn by 2030 and is anticipated to register a CAGR of 7.9%. Food allergy market is driven by various factors such as globalization of food trade, growth in incidences of allergic disorders among consumers. Food allergy is an abnormal response cause by various different food products such as milk, soy, wheat, peanuts and various products which are present in the market. Food allergy hampers the immune response of the body, as sometimes body is not able to fight with certain microbes which enter our body through various food products and therefore leading to food allergic responses.   The report " Food Allergy Market, By Technology (Biosensor-Based, Immunoassay-Based, ELISA PCR Based and Other Technologies), By  Source (Milk, Egg,  Soy, Tree Nuts, Peanuts, Wheat, Seafood and Others), By Diagnosis (Primary and Secondary), By Treatment (Anti Histamines and Adrenaline), By End – Us...
Read more

Infusion Pumps Market is estimated to be US$ 24.63 billion by 2030 with a CAGR of 9.90% during the forecast period

Image
  The Infusion Pumps Market accounted for US$ 12.34 billion in 2020 and is estimated to be US$ 24.63 billion by 2030 and is anticipated to register a CAGR of 9.90%..  An infusion pump infuses fluids, medication or nutrients into a patient's cardiovascular system. It’s generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used. Infusion pumps can administer fluids in ways in which would be impractically expensive or unreliable if performed manually by nursing staff. for instance , they will administer as little as 0.1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient, up to maximum number per hour (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.  Because they will also produce quite high but controlled pressures, they will inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally ...
Read more

Poultry Vaccines Market is estimated to be US$ 3.47 billion by 2030 with a CAGR of 5.8% during the forecast period

Image
  The Poultry Vaccines Market accounted for US$ 1.98 billion in 2020 and is estimated to be US$ 3.47 billion by 2030 and is anticipated to register a CAGR of 5.8%. Vaccination is an important aspect of the chicken flock's health management. Vaccinating birds against a variety of diseases prevents the spread of disease. A vaccine helps to avoid a disease by inducing or enhancing the production of antibodies in the bird's immune system, which then fight the invading causative organisms. Chicken vaccines play a crucial part in keeping poultry flocks healthy. Vaccinating the chicken flock helps to prevent a variety of diseases. Vaccines create antibodies that aid the body of the bird in fighting off invading pathogens. The report " Poultry Vaccines Market, By Type (Live Vaccines and Killed Vaccines), By Application (Chicken and Duck & Goose), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast ...
Read more